Abstract
Anti-GBM antibody disease is a rare autoimmune disorder characterized by circulating autoantibodies directed against specific antigenic targets within the glomerular and alveolar basement membranes. It is extremely uncommon in children, and typically presents with acute renal failure caused by a rapidly progressive glomerulonephritis that is commonly associated with crescentic changes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ang C, Savige J, Dawborn J et al (1998) Anti-glomerular basement membrane (GBM)-antibody-mediated disease with normal renal function. Nephrol Dial Transplant 13(4):935–939
Bailey RR, Simpson IJ, Lynn KL, Neale TJ, Doak PB, McGiven AR (1981) Goodpasture’s syndrome with normal renal function. Clin Nephrol 15(4):211–215
Bolton W (1984) The role of high dose steroids in nephritic syndromes: the case for aggressive use. In: Controversies in nephrology and hypertension. Churchill-Livingston, New York, p 421
Bolton WK (1996) Goodpasture’s syndrome. Kidney Int 50(5):1753–1766
Border WA, Baehler RW, Bhathena D, Glassock RJ (1979) IgA antibasement membrane nephritis with pulmonary hemorrhage. Ann Intern Med 91(1):21–25
Couser WG (1988) Rapidly progressive glomerulonephritis: classification, pathogenetic mechanisms, and therapy. Am J Kidney Dis 11(6):449–464
Dean EG, Wilson GR, Li M et al (2005) Experimental autoimmune goodpasture’s disease: a pathogenetic role for both effector cells and antibody in injury. Kidney Int 67(2):566–575
Donaghy M, Rees A (1983) Cigarette smoking and lung haemorrhage in glomerulonephritis caused by autoantibodies to glomerular basement membrane. Lancet 322(8364):1390–1393
Fervenza FC, Terreros D, Boutaud A et al (1999) Recurrent goodpasture’s disease due to a monoclonal IgA-kappa circulating antibody. Am J Kidney Dis 34(3):549–555
Fox HL, Swann D (2001) Goodpasture syndrome: pathophysiology, diagnosis, and management. Nephrol Nurs J 28(3):305
Goodpasture EW (1919) The significance of certain pulmonary lesions in relation to the etiology of influenza. Am J Med Sci 158(6):863–870
Hellmark T, Burkhardt H, Wieslander J (1999) Goodpasture disease. Characterization of a single conformational epitope as the target of pathogenic autoantibodies. J Biol Chem 274(36):25862–25868
Hudson BG, Tryggvason K, Sundaramoorthy M, Neilson EG (2003) Alport’s syndrome, goodpasture’s syndrome, and type IV collagen. N Engl J Med 348(25):2543–2556
Johnansson C, Hellmark T, Wieslander J (1993) One major epitope in goodpasture’s syndrome. J Am Soc Nephrol 4:608
Kalluri R, Meyers K, Mogyorosi A, Madaio MP, Neilson EG (1997) Goodpasture syndrome involving overlap with wegener’s granulomatosis and anti-glomerular basement membrane disease. J Am Soc Nephrol 8(11):1795–1800
Kefalides NA, Ohno N, Wilson CB (1993) Heterogeneity of antibodies in goodpasture syndrome reacting with type IV collagen. Kidney Int 43(1):85–93
Lerner RA, Glassock RJ, Dixon FJ (1967) The role of anti-glomerular basement membrane antibody in the pathogenesis of human glomerulonephritis. J Exp Med 126(6):989–1004
Levy JB, Turner AN, Rees AJ, Pusey CD (2001) Long-term outcome of anti–glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression. Ann Intern Med 134(11):1033–1042
Matsukura H, Butkowski R, Fish A (1993) The goodpasture antigen: common epitopes in the globular domains of collagen IV. Nephron 64(4):532–539
McLeish KR, Yum MN, Luft FC (1978) Rapidly progressive glomerulonephritis in adults: clinical and histologic correlations. Clin Nephrol 10(2):43–50
Merkel F, Pullig O, Marx M, Netzer KO, Weber M (1994) Course and prognosis of anti-basement membrane antibody (anti-BM-ab)-mediated disease: report of 35 cases. Nephrol Dial Transplant 9(4):372–376
Morrison KE, Mariyama M, Yang-Feng TL, Reeders ST (1991) Sequence and localization of a partial cDNA encoding the human alpha 3 chain of type IV collagen. Am J Hum Genet 49(3):545–554
Netzer KO, Leinonen A, Boutaud A et al (1999) The goodpasture autoantigen. Mapping the major conformational epitope(s) of alpha3(IV) collagen to residues 17–31 and 127–141 of the NC1 domain. J Biol Chem 274(16):11267–11274
Pedchenko V, Bondar O, Fogo AB et al (2010) Molecular architecture of the goodpasture autoantigen in anti-GBM nephritis. N Engl J Med 363(4):343–354
Phelps RG, Rees AJ (1999) The HLA complex in goodpasture’s disease: a model for analyzing susceptibility to autoimmunity. Kidney Int 56(5):1638–1653
Salama AD, Chaudhry AN, Ryan JJ et al (2001) In goodpasture’s disease, CD4(+) T cells escape thymic deletion and are reactive with the autoantigen alpha3(IV)NC1. J Am Soc Nephrol 12(9):1908–1915
Salama AD, Dougan T, Levy JB et al (2002) Goodpasture’s disease in the absence of circulating anti-glomerular basement membrane antibodies as detected by standard techniques. Am J Kidney Dis 39(6):1162–1167
Salama AD, Chaudhry AN, Holthaus KA et al (2003) Regulation by CD25+ lymphocytes of autoantigen-specific T-cell responses in goodpasture’s (anti-GBM) disease. Kidney Int 64(5):1685–1694
Savage CO, Pusey CD, Bowman C, Rees AJ, Lockwood CM (1986) Antiglomerular basement membrane antibody mediated disease in the british isles 1980-4. Br Med J (Clin Res Ed) 292(6516):301–304
Shah MK, Hugghins SY (2002) Characteristics and outcomes of patients with goodpasture’s syndrome. South Med J 95(12):1411–1419
Sinico RA, Radice A, Corace C, Sabadini E, Bollini B (2006) Anti-glomerular basement membrane antibodies in the diagnosis of goodpasture syndrome: a comparison of different assays. Nephrol Dial Transplant 21(2):397–401
Syeda UA, Singer NG, Magrey M (2013) Anti-glomerular basement membrane antibody disease treated with rituximab: a case-based review. Semin Arthritis Rheum 42(6):567–572
Turner N, Mason PJ, Brown R et al (1992) Molecular cloning of the human goodpasture antigen demonstrates it to be the alpha 3 chain of type IV collagen. J Clin Invest 89(2):592–601
Wilson CB, Dixon FJ (1973) Anti-glomerular basement membrane antibody-induced glomerulonephritis. Kidney Int 3(2):74–89
Wu J, Hicks J, Ou C, Singleton D, Borillo J, Lou YH (2001) Glomerulonephritis induced by recombinant collagen IV alpha 3 chain noncollagen domain 1 is not associated with glomerular basement membrane antibody: a potential T cell-mediated mechanism. J Immunol 167(4):2388–2395
Wu J, Hicks J, Borillo J, Glass WF 2nd, Lou YH (2002) CD4(+) T cells specific to a glomerular basement membrane antigen mediate glomerulonephritis. J Clin Invest 109(4):517–524
Zimmerman SW, Varanasi UR, Hoff B (1979) Goodpasture’s syndrome with normal renal function. Am J Med 66(1):163–171
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this entry
Cite this entry
Benchimol, C. (2019). Anti-glomerular Basement Membrane Disease. In: Trachtman, H., Herlitz, L., Lerma, E., Hogan, J. (eds) Glomerulonephritis. Springer, Cham. https://doi.org/10.1007/978-3-319-49379-4_19
Download citation
DOI: https://doi.org/10.1007/978-3-319-49379-4_19
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-49378-7
Online ISBN: 978-3-319-49379-4
eBook Packages: MedicineReference Module Medicine